World

J&J begins take a look at on people after constructive monkey information

Summary

NEW YORK: Johnson & Johnson on Thursday kicked off US human security trials for its Covid-19 vaccine after releasing particulars of a research in monkeys that confirmed its best-performing vaccine candidate supplied robust safety in a single dose. When uncovered […]

NEW YORK: Johnson & Johnson on Thursday kicked off US human security trials for its Covid-19 vaccine after releasing particulars of a research in monkeys that confirmed its best-performing vaccine candidate supplied robust safety in a single dose. When uncovered to the virus, six out of six animals who obtained the vaccine candidate have been utterly shielded from lung illness and 5 out of six have been shielded from an infection as measured by the presence of virus in nasal swabs, in response to the research revealed within the journal Nature.
“This provides us confidence that we will take a look at a single-shot vaccine and be taught whether or not it has a protecting impact in people,” Paul Stoffels, J&J’s chief scientific officer, mentioned. The drugmaker mentioned it had began early-stage human trials within the US and Belgium and would take a look at its vaccine candidate in over 1,000 adults aged 18 to 55 years, in addition to adults aged 65 years and older.
Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: